NCT01716221

An Objective Double-blind Evaluation of Bupropion and Citalopram in an Individual With Friedreich Ataxia

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 1 (actual)
• Sponsor: University of Colorado, Denver · Academic / Other
• Sex: Female
• Age: —
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to document the clinical effects of bupropion and citalopram in a single subject with Friedreich Ataxia.

Detailed description

This is a double blind study with a single subject to objectively document the clinical effects of bupropion and citalopram in a single patient with Friedreich Ataxia (FA), whose disorder symptoms have improved with the use of these medications.

Conditions

• Friedreich Ataxia

Interventions

Type	Name	Description
DRUG	bupropion & Citalopram
DRUG	Bupropion & Placebo
DRUG	Placebo & Citalopram
DRUG	Placebo & Placebo

Timeline

• Start date: 2012-10-01
• Primary completion: 2013-03-01
• Completion: 2013-03-01
• First posted: 2012-10-29
• Last updated: 2016-09-19
• Results posted: 2016-09-19